Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New tool aims to spot struggling caregivers of kids with cancer

NCT ID NCT07321392

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a Spanish version of the Psychosocial Assessment Tool (PAT), a questionnaire for caregivers of children with cancer. The goal is to see if the tool accurately measures family stress and support needs. Researchers will enroll 236 caregivers in Mexico to check if the questionnaire is reliable and valid. If successful, it could help healthcare teams provide better support to families facing childhood cancer.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Psychosocial Assessment Tool (PAT) questionnaire
What this could lead to
If validated, this tool could help hospitals better identify caregivers who need extra support, leading to improved care for families.
What could go wrong
This is a validation study, not a treatment trial. The tool may not prove accurate or useful in all settings, and it does not directly affect the child's cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 236 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Mar 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants: For Spanish-English translation and back-translation According to the guidelines of the International Test Commission \[63\], the participation of an experienced native Mexican translator who is or has been immersed in the English-speaking culture will be required. On the other hand, for translation from English to Spanish, a native translator from an English-speaking country with experience who is immersed in Mexican culture will be required for translation from Spanish to English. For expert judging The participation of 10 psychologists who are experts in the following areas (psycho-oncology, health psychology and behavioural medicine with postgraduate qualifications for expert judging) will be required. For the piloting of the translated and validated version: 10 informal primary caregivers of pediatric cancer patients who come to the National Institute of Pediatrics will be necessary.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Informal primary caregivers of pediatric cancer patients, who verbally state that they have assumed responsibility for care from diagnosis to survival. * Informal primary caregivers of pediatric cancer patients over 18 years of age. * Informal primary caregivers of pediatric cancer patients who can read and write. * Informal primary caregivers of pediatric cancer patients who are receiving chemotherapy and/or radiation therapy. * Informal primary caregivers of pediatric cancer patients who agree to participate in the study. Exclusion Criteria: * Informal primary secondary caregivers of pediatric cancer patients. * Informal primary caregivers of pediatric cancer patients who have participated in the piloting of the study. * Informal primary caregivers of pediatric cancer patients who are receiving palliative care treatment. * Informal primary caregivers of pediatric cancer patients who are in remission.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Informal primary caregivers are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Aquí Nadie se Rinde I.A.P.

    Mexico City, Mexico City, 04120, Mexico